There is considerable interest in optimizing the therapy for important infections in developing
countries and in making the best treatments readily available and inexpensive. There is also …

Objective: The objective of this review is to produce evidence on the prevalence and trends
in the availability of substandard and counterfeit antimicrobials in the global market and its …

Counterfeit and substandard products present a big challenge to any national plan or policy
devised to improve public health. Poor quality drug products are especially a problem in …

Antimicrobial resistance has become a major medical and public health problem worldwide.
This has been brought about by overuse and/or misuse of these drugs especially in …

Objective To explore the evidence available of poor-quality (counterfeit and substandard)
medicines in the literature. Design Systematic review. Data sources Databases used were …

Substandard/counterfeit antimicrobial drugs are a growing global problem. The most
common substandard/counterfeit antimicrobials include beta-lactams (among antibiotics) …

Substandard medicines pose a serious public health risk, especially in the developing
world. Produced by licensed manufacturers, these medicines are the product of poor …

Background Globally, millions of people have been affected by fraudulent pharmaceutical
products, particularly those in developing countries. Although the problem of falsified and …

Approximately 10% of antimicrobials used by humans in low-and middle-income countries
are estimated to be substandard or falsified. In addition to their negative impact on morbidity …

The production of counterfeit or substandard anti-infective drugs is a widespread and under-
recognised problem that contributes to morbidity, mortality, and drug resistance, and leads to …